Published in J R Soc Med on January 01, 1987
Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Thorax (1990) 1.61
Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization. Respir Res (2014) 0.82
Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged. Br J Clin Pharmacol (2000) 0.80
The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can Vet J (1994) 0.77
Management of severe obstructive pulmonary disease with inhaled bronchodilator treatment in a horse. Can Vet J (1993) 0.75
Aerosol delivery systems for bronchial asthma. Postgrad Med J (1996) 0.75
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis Suppl (1982) 1.80
Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis (1973) 1.72
Misplaced confidence in nebulised bronchodilators in severe asthmatic attacks. Br Med J (Clin Res Ed) (1982) 1.03
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Sudden death in asthma. Thorax (1979) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Emergency tracheostomy. Practitioner (1975) 2.18
Use of expandable metal stents in the treatment of bronchial obstruction. Thorax (1989) 2.07
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
A study of a brucellosis epidemic. Ir J Med Sci (1970) 1.99
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Effects of sputum on pulmonary function. Br Med J (1977) 1.94
Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas (1986) 1.87
Evaluation of jet nebulisers for use with gentamicin solution. Thorax (1985) 1.85
Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res (1969) 1.77
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest (1993) 1.60
Resistance to two-phase gas-liquid flow in airways. J Appl Physiol (1970) 1.56
Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax (1986) 1.42
Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest (1989) 1.41
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Selective bronchography using the fibreoptic bronchoscope. Br J Dis Chest (1982) 1.36
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis (1978) 1.33
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis (1983) 1.30
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
The effect of expiratory flow rate on regional lung emptying. Clin Sci (1969) 1.15
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11
Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax (1979) 1.10
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
Pulmonary function in inflammatory bowel disease. Digestion (1978) 1.08
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy. Eur J Respir Dis (1985) 1.08
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (1988) 1.03
The retention of lung secretions during the night in normal subjects. Clin Sci Mol Med Suppl (1978) 1.03
Chest physiotherapy: a review. Eur J Respir Dis (1982) 1.02
Techniques for measuring lung mucociliary clearance. Eur J Respir Dis Suppl (1980) 1.02
The effect of oral aminophylline on lung mucociliary clearance in man. Chest (1981) 1.02
Output characteristics of DeVilbiss No. 40 hand-held jet nebulizers. Eur Respir J (1990) 1.01
Impaired tracheobronchial clearance in bronchiectasis. Thorax (1987) 0.99
Aerosolised pentamidine. Lancet (1989) 0.99
Variability and reproducibility in the measurement of tracheobronchial clearance in healthy subjects and patients with different obstructive lung diseases. Eur Respir J (1988) 0.98
Regional lung clearance of excessive bronchial secretions during chest physiotherapy in patients with stable chronic airways obstruction. Lancet (1979) 0.98
Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest (1986) 0.98
Choice of nebulisers and compressors for delivery of carbenicillin aerosol. Eur J Respir Dis (1986) 0.97
Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis. Eur Respir J (1992) 0.96
Transbronchial lung biopsy through the fibreoptic bronchoscope. Br J Dis Chest (1978) 0.95
Quantitative comparison of 99Tcm-aerosol and 81Krm ventilation images. Clin Phys Physiol Meas (1982) 0.95
Primary pulmonary hypertension: a case report including electronmicroscopic study. Br J Dis Chest (1974) 0.94
Lung mucus production and mucociliary clearance: methods of assessment. Br J Clin Pharmacol (1980) 0.94
Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J (1989) 0.94
Differences between pressurized aerosol and stable dust particles. Chest (1981) 0.93
Mucus clearance from the airways in chronic bronchitis--Smokers and ex-smokers. Bull Eur Physiopathol Respir (1982) 0.93
Drug effects on mucociliary function. Eur J Respir Dis Suppl (1983) 0.93
Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J (1992) 0.92
Tracheobronchial mucociliary clearance in asthma: impairment during remission. Thorax (1985) 0.92
Acceptability of fibreoptic bronchoscopy under local anaesthesia. Practitioner (1978) 0.92
Time course of end-expired carbon monoxide concentration is important in studies of cigarette smoking. Clin Sci (Lond) (1987) 0.91
A model for assessing bronchial mucus transport. J Nucl Med (1984) 0.91
Long-term ipratropium bromide nebuliser therapy and lung mucociliary clearance. Lancet (1982) 0.91
In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest (1987) 0.90
The nature of latent pulmonary involvement in primary biliary cirrhosis. Sarcoidosis (1989) 0.90
Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax (1988) 0.90
Effect of oral N-acetylcysteine on mucus clearance. Br J Dis Chest (1985) 0.89
The importance of aerosol penetration for lung mucociliary clearance studies. Chest (1981) 0.89
Radionuclide demonstration of ventilatory abnormalities in mild asthma. Clin Sci (Lond) (1984) 0.88
Plasma nicotine concentration and the white blood cell count in smokers. Thorax (1986) 0.88
Simple nebuliser modification to enhance alveolar deposition of pentamidine. Lancet (1989) 0.88
Effect of nebulised aerosol size on lung deposition in patients with mild asthma. Thorax (1987) 0.88
Pancoast syndrome caused by a high grade B cell lymphoma. Thorax (1994) 0.88
A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Am J Hosp Pharm (1974) 0.87
Krypton-81m and 5-micron radioaerosol images in asymptomatic asthma: a blind marking assessment. Eur J Nucl Med (1984) 0.87
Spinal abscess due to Listeria monocytogenes in a patient with hepatic cirrhosis. J Pathol (1972) 0.87